Clinical Trials Browser

Phase 2 × Interventional × Head and Neck Cancers - Salivary Gland × Clear all

NCT04910854 2021-06-02

Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Phase 2 Unknown

Head and Neck Cancers - Salivary Gland